Aom 0207
Alternative Names: Aom-0207Latest Information Update: 22 Aug 2023
At a glance
- Originator Hangzhou Adamerck
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Diarrhoea
Most Recent Events
- 22 Aug 2023 Preclinical trials in Diarrhoea (Prevention) in China (unspecified route) (Hangzhou Adamerck pipeline; August 2023)
- 23 Jun 2022 Early research in Diarrhoea in China, Prior to June 2022 (Hangzhou Adamerck pipeline, June 2022)